FUNDAMENTALS:
GILD ( Gilead Sciences ) is that company that found the cure for hepatitis C. The fundamentals are improving again. The industry has not done as well as in others. However, with the recent acquisition of MYR Pharmaceuticals (myr-pharma.com), GILD is currently in phase 3 for the treatment of hepatitis B and D.
***Revenue is also generated when more people catch and/or are dying of covid with their covid treatment called Veklury. Revenue soared around $1.5 billion from Veklury alone.
Target 80 or 165
GILD ( Gilead Sciences ) is that company that found the cure for hepatitis C. The fundamentals are improving again. The industry has not done as well as in others. However, with the recent acquisition of MYR Pharmaceuticals (myr-pharma.com), GILD is currently in phase 3 for the treatment of hepatitis B and D.
***Revenue is also generated when more people catch and/or are dying of covid with their covid treatment called Veklury. Revenue soared around $1.5 billion from Veklury alone.
Target 80 or 165
Capturing the swings of the stock market & currency market. It's a dirty job and equity/currency traders must do it.
相關出版品
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
Capturing the swings of the stock market & currency market. It's a dirty job and equity/currency traders must do it.
相關出版品
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。